Product Information
SODIUM BICARB 650 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0128 per EA under NDC 64980052810. Its NADAC has been published 189 times since Feb 22, 2023.
Strength
650 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980052810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SODIUM BICARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001.30On Market Since
7/20/2020
Pharmacological Classes
Price Statistics
The NADAC for SODIUM BICARB 650 MG TABLET has been published 189 times since Feb 22, 2023, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0128 per EA |
|---|---|
| All-time high | $0.0156 (May 10, 2023) |
| All-time low | $0.0107 (Apr 17, 2024) |
| 52-week high | $0.0130 |
| 52-week low | $0.0126 |
| Median price | $0.0133 |
| Average price | $0.0133 |
| Largest weekly change | -22.9% (Apr 17, 2024) |
| Weeks tracked | 189 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM BICARB 650 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM BICARB 650 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0128 per EA (NDC 64980052810), effective Sep 30, 2026.
How has the price of SODIUM BICARB 650 MG TABLET changed over time?
Over the history we have for it, the NADAC for SODIUM BICARB 650 MG TABLET has declined 6.5%. It has been tracked across 189 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for SODIUM BICARB 650 MG TABLET?
Since Feb 22, 2023, the NADAC for SODIUM BICARB 650 MG TABLET has ranged from a low of $0.0107 (Apr 17, 2024) to a high of $0.0156 (May 10, 2023), with a median of $0.0133 per EA.
Are there cheaper alternatives to SODIUM BICARB 650 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SODIUM BICARB 650 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SODIUM BICARB 650 MG TABLET?
SODIUM BICARB 650 MG TABLET (NDC 64980052810) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.